Janice Brown

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Thomas M. Herndon, Albert Deisseroth, Edvardas Kaminskas et al. · Clinical Cancer Research · 2013 · 241 citations

Medicine, Pharmacology, Pharmacotherapy +17

U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma

R. Angelo de Claro, Karen M. McGinn, Virginia E. Kwitkowski et al. · Clinical Cancer Research · 2012 · 209 citations

Medicine, Oncology, Pharmacology +17

Subvisible Particle Content, Formulation, and Dose of an Erythropoietin Peptide Mimetic Product Are Associated With Severe Adverse Postmarketing Events

Joseph A. Kotarek, Christine Stuart, Silvia H. De Paoli et al. · Journal of Pharmaceutical Sciences · 2016 · 117 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +8

U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia

Firoozeh Alvandi, Virginia E. Kwitkowski, Chia‐Wen Ko et al. · The Oncologist · 2013 · 99 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Identification of protein A media performance attributes that can be monitored as surrogates for retrovirus clearance during extended re-use

Kurt Brorson, Janice Brown, Elizabeth Hamilton et al. · Journal of Chromatography A · 2003 · 74 citations

Life Sciences, Infectious Diseases, Molecular Biology +13